n (%) | Missing, % | |
---|---|---|
N | 188 | |
Age, years (median, IQR) | 71.50 [65.00, 79.00] | 0.0 |
Sex | ||
Female | 99 (52.7) | 0.0 |
Male | 89 (47.3) | |
ASA Score | ||
I | 17 (11.6) | 22.3 |
II | 105 (71.9) | |
III | 24 (16.4) | |
IV | 0 (0.0) | |
Tobacco | ||
Current smoker | 33 (17.6) | 0.5 |
Former or never smoker | 154 (82.4) | |
Tumour localization | ||
Right-sided | 103 (54.8) | 0.0 |
Left-sided | 85 (45.2) | |
Preoperative liver metastases | ||
No | 174 (92.6) | 0.0 |
Yes | 14 (7.4) | |
Preoperative lung metastases | ||
No | 182 (96.8) | 0.0 |
Yes | 6 (3.2) | |
Urgency | ||
Elective | 157 (83.5) | 0.0 |
Acute | 31 (16.5) | |
Procedure type | ||
Right hemicolectomy including transverse resection | 104 (55.3) | 0.0 |
Left hemicolectomy | 76 (40.4) | |
Colectomy | 8 (4.3) | |
Perioperative blood transfusion | ||
No | 162 (86.6) | 0.5 |
Yes | 25 (13.4) | |
Postoperative complications (Clavien-Dindo) | ||
0 (no complications) | 126 (67.4) | 0.5 |
1–2 | 13 (7.0) | |
3–4 | 40 (21.4) | |
5 (death) | 8 (4.3) | |
UICC stage | ||
II | 90 (47.9) | 0.0 |
III | 82 (43.6) | |
IV | 16 (8.5) | |
Histological type | ||
Adenocarcinoma NOS, high or moderate differentiated | 124 (66.0) | 0.0 |
Adenocarcinoma, poorly differentiated | 32 (17.0) | |
Mucinous adenocarcinoma | 29 (15.4) | |
Signet ring cell carcinoma | 2 (1.1) | |
Other carcinoma type | 1 (0.5) | |
Microsatellite status | ||
MSS | 144 (76.6) | 0.0 |
MSI | 44 (23.4) | |
Resection margin | ||
R0 (no residual tumor cells) | 170 (94.4) | 4.3 |
R1 (micro- or macroscopic residual tumor) | 10 (5.6) | |
Adjuvant chemotherapy | ||
No | 107 (56.9) | 0.0 |
Yes | 81 (43.1) | |
Follow-up time, months (median, IQR) | 41.72 [10.56, 59.82] | 0.0 |